471820 Stock Chart & Stats
₩4070.00
₩310.00(8.24%)
―
--
Day’s Range― - ―
52-Week Range₩3,410.00 - ₩7,690.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)6.87K
Market Cap
₩44.12B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)13.3
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,302,879
10 Day Avg. Volume5,676
30 Day Avg. Volume6,869
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
471820 FAQ
What was Cellromax Science Co., Ltd.’s price range in the past 12 months?
Cellromax Science Co., Ltd. lowest stock price was ₩3410.00 and its highest was ₩7690.00 in the past 12 months.
What is Cellromax Science Co., Ltd.’s market cap?
Cellromax Science Co., Ltd.’s market cap is ₩44.12B.
When is Cellromax Science Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cellromax Science Co., Ltd.’s earnings last quarter?
Cellromax Science Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩106.672 earnings per share for the quarter, beating the consensus estimate of N/A by ₩106.672.
Is Cellromax Science Co., Ltd. overvalued?
According to Wall Street analysts Cellromax Science Co., Ltd.’s price is currently Undervalued.
Does Cellromax Science Co., Ltd. pay dividends?
Cellromax Science Co., Ltd. does not currently pay dividends.
What is Cellromax Science Co., Ltd.’s EPS estimate?
Cellromax Science Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cellromax Science Co., Ltd. have?
Cellromax Science Co., Ltd. has 11,302,879 shares outstanding.
What happened to Cellromax Science Co., Ltd.’s price movement after its last earnings report?
Cellromax Science Co., Ltd. reported an EPS of ₩106.672 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.789%.
Which hedge fund is a major shareholder of Cellromax Science Co., Ltd.?
Currently, no hedge funds are holding shares in KR:471820
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HLB PANAGENE Co. LTD.
―
LabGenomics Co., Ltd.
―
Gene Bio Tech Co., Ltd.
―
WOOJUNG BIO, Inc.
―
Cell Bio Human Tech Co., Ltd
―